New AI Reads Brain Scans to Spot Autism and Alzheimer's Early
This could lead to earlier diagnosis and better treatment for brain disorders.
Researchers propose IC-GNN, an atlas-anchored model that forms individualized functional communities directly over atlas-defined brain regions from resting-state fMRI data. It refines community-guided connections and adapts shared regional weights to each subject’s community context, enabling individualized modeling and group-level comparisons.
Across more than 30,000 participants from ABIDE (autism spectrum disorder), ADNI (Alzheimer’s disease), and the UK Biobank (depression), IC-GNN achieved the highest performance compared with 15 baseline methods. The individualized communities were reproducible within scans and across sessions and carried predictive power on their own. IC-GNN also identified disease-related shifts in community organization that align with established literature, highlighting a promising approach for disease prediction and biomarker discovery.
- IC-GNN is an AI that analyzes brain scans to predict autism, Alzheimer's, and depression with higher accuracy than standard methods.
- It creates personalized brain maps, accounting for each person's unique brain wiring, which improves detection.
- Tested on over 30,000 people, it outperformed 15 other methods and identified consistent disease-related brain patterns.
Why It Matters
Could lead to earlier diagnosis and personalized treatment for brain disorders, improving outcomes and quality of life.